Detroit, MI, United States of America

Aslamuzzaman Kazi

USPTO Granted Patents = 4 


Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Tampa, FL (US) (2012)
  • Detroit, MI (US) (2009 - 2014)
  • Detroit, MA (US) (2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Aslamuzzaman Kazi

Introduction

Aslamuzzaman Kazi is a notable inventor based in Detroit, MI (US). He has made significant contributions to the field of science and technology, particularly in the area of cancer research. With a total of 4 patents to his name, Kazi's work has the potential to impact the medical community positively.

Latest Patents

Kazi's latest patents include innovative methods for inhibiting proteasome activity, which is crucial in reducing tumor cell growth. His work on (−)-Epigallocatechin gallate derivatives showcases his commitment to developing effective treatments for cancer. These compounds are designed to administer an effective amount of a formula that can significantly hinder tumor cell proliferation.

Career Highlights

Throughout his career, Kazi has worked with prestigious institutions such as The Hong Kong Polytechnic University and Wayne State University. His experience in these academic environments has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Some of Kazi's notable coworkers include Tak-Hang Chan and Wai-Har Lam. Their collaborative efforts have contributed to the advancement of research in cancer treatment and have fostered a productive academic environment.

Conclusion

Aslamuzzaman Kazi's innovative work and dedication to cancer research exemplify the impact that inventors can have on society. His patents and collaborations highlight the importance of scientific inquiry in developing new medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…